Skip to main content
. 2020 Jan 6;8:e8308. doi: 10.7717/peerj.8308

Table 2. Patient characteristics and outcomes of the included cycles with double embryo transfer.

Variable Included cycles (n = 2038) Prognosis P-valuea
Favorable (n = 812) Average (n = 906) Poor (n = 320)
Maternal ageb,d 37.8 ± 2.7 37.6 ± 2.6 38.0 ± 2.8 37.9 ± 2.7 0.007
Maternal BMI 21.2 ± 2.5 21.1 ± 2.5 21.2 ± 2.5 21.2 ± 2.4 0.957
Cause of infertility
 Tubal pathology 682 (33.5) 251 (30.9) 322 (35.5) 109 (34.1) 0.124
 Endometriosis 195 (9.6) 76 (9.5) 89 (9.8) 30 (9.4) 0.940
 Male factorc,d 713 (35.0) 265 (32.6) 316 (34.9) 132 (41.3) <0.001
 Unexplainedb,d 230 (11.3) 114 (14.0) 90 (9.9) 26 (8.1) 0.004
 Othersb,d 218 (10.7) 106 (13.1) 89 (9.8) 23 (7.2) 0.008
Type of infertility (%) 0.069
 Primary infertility 1,665 (81.7) 647 (79.7) 760 (83.9) 258 (80.6)
 Secondary infertility 373 (18.3) 165 (20.3) 146 (16.1) 62 (19.4)
Fertilization method (%)b,d 0.006
 IVF 1,257 (61.7) 534 (65.8) 541 (59.7) 182 (56.9)
 ICSI 781 (38.3) 278 (34.2) 365 (40.3) 138 (43.1)
Length of embryo cryopreservation (month) 5.7 ± 3.8 5.5 ± 3.9 5.8 ± 3.7 5.8 ± 4.1 0.414
Survival rate (%) 4,119/4,213 (97.8) 1,642/1,681 (97.7) 1,832/1,874 (97.8) 645/658 (98.0) 0.879
Damaged blastomere (%) 0.367
 Yes 221 (10.8) 80 (9.9) 108 (11.9) 33 (10.3)
 No 1,817 (89.2) 732 (90.1) 798 (88.1) 287 (89.7)
Endometrial thickness (mm) 9.1 ± 1.6 9.1 ± 1.6 9.1 ± 1.6 8.9 ± 1.7 0.136
Endometrial preparation (%) 0.367
 Natural cycles 126 (6.2) 41 (5.0) 65 (7.2) 20 (6.3)
 HRT cycles 1,912 (93.8) 771 (95.0) 841 (92.8) 300 (93.7)
No. of good-quality embryos transferredb,c,d 1.1 ± 0.9 1.9 ± 0.1 0.8 ± 0.6 0 <0.001
Clinical pregnancyb,c,d 816 (40.0) 374 (46.1) 346 (38.2) 96 (30.0) <0.001
Implantation rateb,c,d 1,008/4076 (24.7) 470/1,624 (28.9) 430/1,812 (23.7) 108/640 (16.9) <0.001
Twin pregnancyc,d 192 (23.5) 102/374 (27.3) 78/346 (22.5) 12/96 (12.5) 0.008
Live birthb,c,d 734 (36.0) 335 (41.3) 318 (35.1) 81 (25.3) <0.001

Notes:

a

P-value for global comparison between the three groups.

b

Significant comparison between women with favorable and average prognosis.

c

Significant comparison between women with average and poor prognosis.

d

Significant comparison between women with favorable and poor prognosis.